Molecular mechanisms governing the differentiation and expansion of myeloid-derived suppressor cells

TL;DR

This paper reviews how myeloid-derived suppressor cells develop and expand, focusing on their role in cancer immune evasion and potential therapeutic targets.

Contribution

The paper provides a comprehensive review of signaling pathways and regulatory factors governing MDSC differentiation and expansion.

Findings

Key signaling pathways like JAK/STAT, NF-κB, and Notch are central to MDSC biology.

Regulatory cytokines, metabolic factors, and epigenetic modifications influence MDSC development.

Understanding these mechanisms can lead to novel cancer immunotherapies targeting MDSC-mediated immunosuppression.

Abstract

Myeloid-derived suppressor cells (MDSCs) play critical roles in tumor immune evasion. These heterogeneous cells are broadly classified into granulocytic (G-MDSC), monocytic (M-MDSC), and their immature precursors, early-stage MDSCs (e-MDSCs). Elucidating their differentiation and expansion mechanisms is crucial for advancing cancer immunotherapy. This review examines the key signaling pathways (e.g., JAK/STAT, NF-κB, Notch), regulatory cytokines, metabolic factors, and epigenetic modifications central to MDSC biology. A comprehensive understanding of these intricate networks provides valuable insights into tumor immune evasion and facilitates the identification of novel therapeutic targets designed to overcome MDSC-mediated immunosuppression.

Figures